Stockreport

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Eton Pharmaceuticals, Inc.  (ETON) 
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm Check Earnings Report
PDF Q4 2025 product sales of $21.3 million, representing 83% growth over Q4 2024Q4 2025 basic GAAP EPS of $0.06, fully diluted GAAP EPS of $0.05, basic non-GAAP EPS of $0.21 [Read more]